THC, short for delta-9-tetrahydrocannabinol, is the main compound responsible for the high associated with cannabis. It also has medical relevance, but describing it as a “miracle molecule” hides the decisions that matter: which condition is being treated, with which preparation, and at what risk.
This guide separates the effects of THC from evidence for specific medicines. The presence of an active compound in a plant is a starting point for research, not proof that every product containing it is an effective treatment.
How THC affects the body
THC acts on the body's cannabinoid signalling system, including receptors involved in brain function. Changes in perception, mood and thinking are part of its drug effects. CBD is another cannabinoid, with a different effect profile; the two names should not be used interchangeably. NCCIH: cannabis, marijuana and cannabinoids.
Feeling an effect establishes that a substance is active. It does not establish whether a health condition is improving. For medical use, the relevant questions concern symptom relief, daily functioning and adverse effects, assessed against an agreed treatment goal.
Which cannabinoid medicines have established uses?
Examples include dronabinol, a form of THC, and nabilone, a related synthetic cannabinoid. These medicines can be prescribed for chemotherapy-related nausea and vomiting when other medicines have not worked adequately. Dronabinol also treats appetite loss and weight loss in people with AIDS. MedlinePlus: dronabinol, MedlinePlus: nabilone.
Those are specific medicines with defined prescribing information. They do not mean that any THC-containing flower or edible is approved for the same purpose. US approval also does not establish a product's approval, availability or prescribing rules in Thailand.
The distinction is easy to miss in a headline. “A cannabinoid medicine has an approved use” is a narrower and more useful statement than “THC treats disease.” Ask a clinician whether the proposed preparation matches the evidence relevant to your condition.
What does the pain research show?
AHRQ's living review found small improvements in chronic pain with some THC-containing products, together with increased dizziness, sedation or nausea. Much of the research concerned neuropathic pain; long-term evidence and evidence for other pain conditions were limited. AHRQ: cannabis and other plant-based treatments for chronic pain.
That makes follow-up central to the decision. For example, a useful record might track whether pain interferes less with walking or sleep and whether unwanted effects make daily activities harder. The purpose is to help a clinician judge the whole result, rather than treating any reduction in a symptom score as sufficient reason to continue.
Evidence about one symptom should not be extended to unrelated claims about curing cancer, reversing neurological disease or treating every cause of insomnia. Each claim needs its own clinical evidence.
Risks to include in the discussion
THC-containing cannabis can impair the skills needed for driving, including coordination and reaction time. Familiarity with the sensation does not establish driving fitness. CDC: cannabis and driving.
Anxiety and paranoia are possible, and psychiatric history deserves specific discussion. CDC: cannabis and mental health. Regular use can also become difficult to control; tell the prescriber if you are using more than planned or repeatedly struggling to cut back. CDC: cannabis use disorder.
Bring a complete medicines list, including supplements and non-prescription products. Ask the prescriber or pharmacist to review the actual preparation and relevant interactions. Do not assume a product is compatible with another medicine because both were obtained legally.
Read the label before judging the product
A THC percentage describes concentration. It does not tell you whether the product is suitable for your diagnosis, how your body will respond or whether the treatment is working. A strain name, an aroma description and the word “premium” answer none of those questions.
Check that you can identify the preparation, its cannabinoid content and the instructions supplied for its prescribed use. If the units or directions are unclear, ask the dispensing professional to explain them. Do not copy another person's amount or translate between a flower percentage and an oil label without professional guidance.
Questions worth asking before treatment
- What symptom are we targeting, and why is this option being considered?
- What evidence applies to this product and my condition?
- Which alternatives have a stronger or more established evidence base?
- What should I do if I experience distress or excessive sedation?
- When will we decide whether continuing is worthwhile?
Read THC versus CBD for a comparison of the compounds, or our cannabis benefits and risks guide for a broader assessment. Our Thailand prescription guide covers preparation for a local consultation.
Editorial update: 6 September 2026. This revision replaces the former “miracle molecule” framing. It does not recommend a product or dose.
